The associated risk of MALO became marginally insignificant (0.90 [0.79, 1.02]), although there were associated significant risk reductions in bleeding varices (0.79 [0.64, 0.96]), ascites and SBP (0.77 [0.65, 0.92]), and liver failure (0.85 [0.74, 0.97]). 3.4.6.
← all excerpts
Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri-Menopausal MASLD.
1
—
—